Opibind P 37.5mg/325mg Tablet
Marketer
Glenwood Biotech Pvt Ltd
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Opibind P 37.5mg/325mg Tablet
Combiflex-P 37.5mg/325mg tablets offer dual pain relief for moderate to severe discomfort. Dosage and treatment duration should strictly follow your physician's instructions. Consumption with or without food is acceptable; however, if stomach upset occurs, take it with food. Consistent medication intake is crucial; discontinue only under your doctor's guidance. Potential side effects include nausea, vomiting, dry mouth, dizziness, and constipation, generally mild and transient. Report any rash or allergic reaction promptly. Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding.
Uses of Opibind P 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Opibind P 37.5mg/325mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Opibind P 37.5mg/325mg tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Opibind P 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Opibind P 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Opibind P 37.5mg/325mg tablet should be swallowed whole; do not break, crush, or chew it. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Opibind P 37.5mg/325mg Tablet works:
Combiflam-P, a 37.5mg/325mg tablet, merges tramadol and paracetamol to alleviate intense pain. Tramadol, an opioid analgesic, reduces pain perception by interrupting pain signals to the brain. Paracetamol achieves pain relief by inhibiting the release of specific pain-inducing chemicals.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Opibind P 37.5mg/325mg Tablet use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Opibind P 37.5mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Using Opibind P 37.5mg/325mg tablets while breastfeeding is likely safe. Available human data indicates minimal infant risk. However, contact a physician promptly if your baby exhibits excessive sleepiness, feeding difficulties, respiratory distress, or unusual lethargy.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Opibind P 37.5mg/325mg tablets.
KidneyCAUTION
Patients with kidney impairment should use Opibind P 37.5mg/325mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Opibind P 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Opibind P 37.5mg/325mg tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Opibind P 37.5mg/325mg Tablet :
Should you forget to take your Opibind P 37.5mg/325mg Tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Opibind P 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently